{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:57:49Z","timestamp":1790503069112,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":163,"publisher":"Springer New York","isbn-type":[{"value":"9781493989577","type":"print"},{"value":"9781493989584","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:00:00Z","timestamp":1544572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-8958-4_3","type":"book-chapter","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T14:26:42Z","timestamp":1544538402000},"page":"53-81","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["IgM Natural Autoantibodies in Physiology and the Treatment of Disease"],"prefix":"10.1007","author":[{"given":"Mahboobeh","family":"Fereidan-Esfahani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Nayfeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Warrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"issue":"14","key":"3_CR1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ (2001) Complement. First of two parts. N Engl J Med 344(14):1058\u20131066","journal-title":"N Engl J Med"},{"issue":"1\u20133","key":"3_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/IR:36:1:197","volume":"36","author":"FR Toapanta","year":"2006","unstructured":"Toapanta FR, Ross TM (2006) Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. Immunol Res 36(1\u20133):197\u2013210","journal-title":"Immunol Res"},{"issue":"6","key":"3_CR3","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.berh.2015.04.010","volume":"28","author":"A Aggarwal","year":"2014","unstructured":"Aggarwal A (2014) Role of autoantibody testing. Best Pract Res Clin Rheumatol 28(6):907\u2013920","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"3_CR4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pathophys.2008.07.002","volume":"15","author":"A Zaichik","year":"2008","unstructured":"Zaichik A, Churilov LP, Utekhin VJ (2008) Autoimmune regulation of genetically determined cell functions in health and disease. Pathophysiology 15(3):191\u2013207","journal-title":"Pathophysiology"},{"issue":"1\u20132","key":"3_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08830180701848995","volume":"27","author":"A Piro","year":"2008","unstructured":"Piro A, Tagarelli A, Tagarelli G et al (2008) Paul Ehrlich: the Nobel Prize in physiology or medicine 1908. Int Rev Immunol 27(1\u20132):1\u201317","journal-title":"Int Rev Immunol"},{"issue":"6","key":"3_CR6","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/eji.1830270635","volume":"27","author":"M Haury","year":"1997","unstructured":"Haury M, Sundblad A, Grandien A et al (1997) The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol 27(6):1557\u20131563","journal-title":"Eur J Immunol"},{"issue":"18","key":"3_CR7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0161-5890(01)00025-6","volume":"37","author":"M Boes","year":"2000","unstructured":"Boes M (2000) Role of natural and immune IgM antibodies in immune responses. Mol Immunol 37(18):1141\u20131149","journal-title":"Mol Immunol"},{"issue":"3","key":"3_CR8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1172\/JCI31578","volume":"117","author":"E Meffre","year":"2007","unstructured":"Meffre E, Salmon JE (2007) Autoantibody selection and production in early human life. J Clin Invest 117(3):598\u2013601","journal-title":"J Clin Invest"},{"issue":"3","key":"3_CR9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1172\/JCI29943","volume":"117","author":"Y Merbl","year":"2007","unstructured":"Merbl Y, Zucker-Toledano M, Quintana FJ, Cohen IR (2007) Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J Clin Invest 117(3):712\u2013718","journal-title":"J Clin Invest"},{"issue":"9","key":"3_CR10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ncprheum0895","volume":"4","author":"K Elkon","year":"2008","unstructured":"Elkon K, Casali P (2008) Nature and functions of autoantibodies. Nat Clin Pract Rheumatol 4(9):491\u2013498","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"3","key":"3_CR11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.4049\/jimmunol.1102107","volume":"188","author":"SV Kaveri","year":"2012","unstructured":"Kaveri SV, Silverman GJ, Bayry J (2012) Natural IgM in immune equilibrium and harnessing their therapeutic potential. J Immunol 188(3):939\u2013945","journal-title":"J Immunol"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.immunol.16.1.545","volume":"16","author":"MC Carroll","year":"1998","unstructured":"Carroll MC (1998) The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 16:545\u2013568","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"3_CR13","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/1521-4141(200105)31:5<1310::AID-IMMU1310>3.0.CO;2-N","volume":"31","author":"N Sakamoto","year":"2001","unstructured":"Sakamoto N, Shibuya K, Shimizu Y et al (2001) A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues. Eur J Immunol 31(5):1310\u20131316","journal-title":"Eur J Immunol"},{"issue":"5","key":"3_CR14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/80886","volume":"1","author":"A Shibuya","year":"2000","unstructured":"Shibuya A, Sakamoto N, Shimizu Y et al (2000) Fc alpha\/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol 1(5):441\u2013446","journal-title":"Nat Immunol"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0105-2896.2005.00278.x","volume":"206","author":"CS Kaetzel","year":"2005","unstructured":"Kaetzel CS (2005) The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev 206:83\u201399","journal-title":"Immunol Rev"},{"issue":"7","key":"3_CR16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1084\/jem.190.7.915","volume":"190","author":"FE Johansen","year":"1999","unstructured":"Johansen FE, Pekna M, Norderhaug IN et al (1999) Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor\/secretory component-deficient mice. J Exp Med 190(7):915\u2013922","journal-title":"J Exp Med"},{"issue":"9","key":"3_CR17","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.4049\/jimmunol.1500222","volume":"194","author":"H Kubagawa","year":"2015","unstructured":"Kubagawa H, Carroll MC, Jacob CO et al (2015) Nomenclature of Toso, Fas apoptosis inhibitory molecule 3, and IgM FcR. J Immunol 194(9):4055\u20134057","journal-title":"J Immunol"},{"key":"3_CR18","first-page":"3","volume":"382","author":"H Kubagawa","year":"2014","unstructured":"Kubagawa H, Kubagawa Y, Jones D et al (2014) The old but new IgM Fc receptor (FcmuR). Curr Top Microbiol Immunol 382:3\u201328","journal-title":"Curr Top Microbiol Immunol"},{"issue":"12","key":"3_CR19","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1084\/jem.20091107","volume":"206","author":"H Kubagawa","year":"2009","unstructured":"Kubagawa H, Oka S, Kubagawa Y et al (2009) Identity of the elusive IgM Fc receptor (FcmuR) in humans. J Exp Med 206(12):2779\u20132793","journal-title":"J Exp Med"},{"issue":"3","key":"3_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/intimm\/dxp121","volume":"22","author":"H Shima","year":"2010","unstructured":"Shima H, Takatsu H, Fukuda S et al (2010) Identification of TOSO\/FAIM3 as an Fc receptor for IgM. Int Immunol 22(3):149\u2013156","journal-title":"Int Immunol"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.immunol.20.100301.064833","volume":"20","author":"R Berland","year":"2002","unstructured":"Berland R, Wortis HH (2002) Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20:253\u2013300","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"3_CR22","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/eji.1830230626","volume":"23","author":"CJ Peaker","year":"1993","unstructured":"Peaker CJ, Neuberger MS (1993) Association of CD22 with the B cell antigen receptor. Eur J Immunol 23(6):1358\u20131363","journal-title":"Eur J Immunol"},{"issue":"7","key":"3_CR23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrrheum.2014.54","volume":"10","author":"J Muller","year":"2014","unstructured":"Muller J, Nitschke L (2014) The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease. Nat Rev Rheumatol 10(7):422\u2013428","journal-title":"Nat Rev Rheumatol"},{"issue":"5288","key":"3_CR24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1126\/science.274.5288.798","volume":"274","author":"TL O'Keefe","year":"1996","unstructured":"O'Keefe TL, Williams GT, Davies SL et al (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274(5288):798\u2013801","journal-title":"Science"},{"key":"3_CR25","first-page":"96","volume":"2","author":"J Jellusova","year":"2011","unstructured":"Jellusova J, Nitschke L (2011) Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22. Front Immunol 2:96","journal-title":"Front Immunol"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","volume":"19","author":"RR Hardy","year":"2001","unstructured":"Hardy RR, Hayakawa K (2001) B cell development pathways. Annu Rev Immunol 19:595\u2013621","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"3_CR27","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","volume":"112","author":"TW LeBien","year":"2008","unstructured":"LeBien TW, Tedder TF (2008) B lymphocytes: how they develop and function. Blood 112(5):1570\u20131580","journal-title":"Blood"},{"issue":"6","key":"3_CR28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0092-8674(89)90748-4","volume":"59","author":"LA Herzenberg","year":"1989","unstructured":"Herzenberg LA, Herzenberg LA (1989) Toward a layered immune system. Cell 59(6):953\u2013954","journal-title":"Cell"},{"issue":"6","key":"3_CR29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1471-4906(03)00119-4","volume":"24","author":"JB Chung","year":"2003","unstructured":"Chung JB, Silverman M, Monroe JG (2003) Transitional B cells: step by step towards immune competence. Trends Immunol 24(6):343\u2013349","journal-title":"Trends Immunol"},{"issue":"1","key":"3_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/eji.1830230104","volume":"23","author":"GJ Deenen","year":"1993","unstructured":"Deenen GJ, Kroese FG (1993) Kinetics of peritoneal B-1a cells (CD5 B cells) in young adult mice. Eur J Immunol 23(1):12\u201316","journal-title":"Eur J Immunol"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1749-6632.1992.tb24610.x","volume":"651","author":"AB Kantor","year":"1992","unstructured":"Kantor AB, Stall AM, Adams S et al (1992) Adoptive transfer of murine B-cell lineages. Ann N Y Acad Sci 651:168\u2013169","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"3_CR32","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1073\/pnas.89.8.3320","volume":"89","author":"AB Kantor","year":"1992","unstructured":"Kantor AB, Stall AM, Adams S et al (1992) Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci U S A 89(8):3320\u20133324","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"3_CR33","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1073\/pnas.0511305103","volume":"103","author":"JW Tung","year":"2006","unstructured":"Tung JW, Mrazek MD, Yang Y et al (2006) Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse. Proc Natl Acad Sci U S A 103(16):6293\u20136298","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-065X.1986.tb01503.x","volume":"93","author":"LA Herzenberg","year":"1986","unstructured":"Herzenberg LA, Stall AM, Lalor PA et al (1986) The Ly-1 B cell lineage. Immunol Rev 93:81\u2013102","journal-title":"Immunol Rev"},{"issue":"1","key":"3_CR35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1084\/jem.157.1.202","volume":"157","author":"K Hayakawa","year":"1983","unstructured":"Hayakawa K, Hardy RR, Parks DR et al (1983) The \u201cLy-1 B\u201d cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med 157(1):202\u2013218","journal-title":"J Exp Med"},{"issue":"14","key":"3_CR36","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1073\/pnas.1121632109","volume":"109","author":"EE Ghosn","year":"2012","unstructured":"Ghosn EE, Yamamoto R, Hamanaka S et al (2012) Distinct B-cell lineage commitment distinguishes adult bone marrow hematopoietic stem cells. Proc Natl Acad Sci U S A 109(14):5394\u20135398","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3_CR37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1074-7613(01)00129-7","volume":"14","author":"F Martin","year":"2001","unstructured":"Martin F, Oliver AM, Kearney JF (2001) Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14(5):617\u2013629","journal-title":"Immunity"},{"issue":"13","key":"3_CR38","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1084\/jem.20080979","volume":"205","author":"YS Choi","year":"2008","unstructured":"Choi YS, Baumgarth N (2008) Dual role for B-1a cells in immunity to influenza virus infection. J Exp Med 205(13):3053\u20133064","journal-title":"J Exp Med"},{"issue":"1","key":"3_CR39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1084\/jem.20101499","volume":"208","author":"DO Griffin","year":"2011","unstructured":"Griffin DO, Holodick NE, Rothstein TL (2011) Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med 208(1):67\u201380","journal-title":"J Exp Med"},{"issue":"34","key":"3_CR40","doi-asserted-by":"crossref","first-page":"30707","DOI":"10.1074\/jbc.M202460200","volume":"277","author":"SC Wong","year":"2002","unstructured":"Wong SC, Chew WK, Tan JE et al (2002) Peritoneal CD5+ B-1 cells have signaling properties similar to tolerant B cells. J Biol Chem 277(34):30707\u201330715","journal-title":"J Biol Chem"},{"issue":"10","key":"3_CR41","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/eji.1830161021","volume":"16","author":"K Hayakawa","year":"1986","unstructured":"Hayakawa K, Hardy RR, Stall AM et al (1986) Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur J Immunol 16(10):1313\u20131316","journal-title":"Eur J Immunol"},{"issue":"10","key":"3_CR42","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.4049\/jimmunol.160.10.4776","volume":"160","author":"M Boes","year":"1998","unstructured":"Boes M, Esau C, Fischer MB et al (1998) Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol 160(10):4776\u20134787","journal-title":"J Immunol"},{"issue":"4","key":"3_CR43","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4049\/jimmunol.1401880","volume":"194","author":"TT Nguyen","year":"2015","unstructured":"Nguyen TT, Elsner RA, Baumgarth N (2015) Natural IgM prevents autoimmunity by enforcing B cell central tolerance induction. J Immunol 194(4):1489\u20131502","journal-title":"J Immunol"},{"issue":"13","key":"3_CR44","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1073\/pnas.88.13.5640","volume":"88","author":"AA Freitas","year":"1991","unstructured":"Freitas AA, Viale AC, Sundblad A et al (1991) Normal serum immunoglobulins participate in the selection of peripheral B-cell repertoires. Proc Natl Acad Sci U S A 88(13):5640\u20135644","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032713-120140","volume":"33","author":"JF Kearney","year":"2015","unstructured":"Kearney JF, Patel P, Stefanov EK et al (2015) Natural antibody repertoires: development and functional role in inhibiting allergic airway disease. Annu Rev Immunol 33:475\u2013504","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"3_CR46","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.4049\/jimmunol.1500251","volume":"194","author":"PS Patel","year":"2015","unstructured":"Patel PS, Kearney JF (2015) Neonatal exposure to pneumococcal phosphorylcholine modulates the development of house dust mite allergy during adult life. J Immunol 194(12):5838\u20135850","journal-title":"J Immunol"},{"issue":"5","key":"3_CR47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.nbt.2009.03.016","volume":"25","author":"HP Vollmers","year":"2009","unstructured":"Vollmers HP, Brandlein S (2009) Natural antibodies and cancer. New Biotechnol 25(5):294\u2013298","journal-title":"New Biotechnol"},{"issue":"11","key":"3_CR48","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.4049\/jimmunol.1402771","volume":"194","author":"A Madi","year":"2015","unstructured":"Madi A, Bransburg-Zabary S, Maayan-Metzger A, Dar G, Ben-Jacob E, Cohen IR (2015) Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera. J Immunol 194(11):5272\u20135281","journal-title":"J Immunol"},{"key":"3_CR49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.18.1.709","volume":"18","author":"B Heyman","year":"2000","unstructured":"Heyman B (2000) Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu Rev Immunol 18:709\u2013737","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"3_CR50","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.167.6.1999","volume":"167","author":"B Heyman","year":"1988","unstructured":"Heyman B, Pilstrom L, Shulman MJ (1988) Complement activation is required for IgM-mediated enhancement of the antibody response. J Exp Med 167(6):1999\u20132004","journal-title":"J Exp Med"},{"issue":"5447","key":"3_CR51","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1126\/science.286.5447.2156","volume":"286","author":"AF Ochsenbein","year":"1999","unstructured":"Ochsenbein AF, Fehr T, Lutz C et al (1999) Control of early viral and bacterial distribution and disease by natural antibodies. Science 286(5447):2156\u20132159","journal-title":"Science"},{"issue":"1","key":"3_CR52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.chom.2007.01.002","volume":"1","author":"ZH Zhou","year":"2007","unstructured":"Zhou ZH, Zhang Y, Hu YF et al (2007) The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1(1):51\u201361","journal-title":"Cell Host Microbe"},{"issue":"10","key":"3_CR53","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nm933","volume":"9","author":"S Stager","year":"2003","unstructured":"Stager S, Alexander J, Kirby AC, Botto M, Rooijen NV, Smith DF et al (2003) Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses. Nat Med 9(10):1287\u20131292","journal-title":"Nat Med"},{"issue":"3","key":"3_CR54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-3083.2003.01314.x","volume":"58","author":"H Kohler","year":"2003","unstructured":"Kohler H, Bayry J, Nicoletti A et al (2003) Natural autoantibodies as tools to predict the outcome of immune response? Scand J Immunol 58(3):285\u2013289","journal-title":"Scand J Immunol"},{"issue":"7","key":"3_CR55","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/JVI.02128-06","volume":"81","author":"JP Jayasekera","year":"2007","unstructured":"Jayasekera JP, Moseman EA, Carroll MC (2007) Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol 81(7):3487\u20133494","journal-title":"J Virol"},{"issue":"13","key":"3_CR56","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1084\/jem.20100034","volume":"207","author":"RR Rapaka","year":"2010","unstructured":"Rapaka RR, Ricks DM, Alcorn JF et al (2010) Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J Exp Med 207(13):2907\u20132919","journal-title":"J Exp Med"},{"issue":"Suppl 8","key":"3_CR57","doi-asserted-by":"crossref","first-page":"I86","DOI":"10.1016\/j.vaccine.2008.11.057","volume":"26","author":"S Fernandez Gonzalez","year":"2008","unstructured":"Fernandez Gonzalez S, Jayasekera JP, Carroll MC (2008) Complement and natural antibody are required in the long-term memory response to influenza virus. Vaccine 26(Suppl 8):I86\u2013I93","journal-title":"Vaccine"},{"key":"3_CR58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-cellbio-111315-125315","volume":"33","author":"PM Henson","year":"2017","unstructured":"Henson PM (2017) Cell removal: efferocytosis. Annu Rev Cell Dev Biol 33:127\u2013144","journal-title":"Annu Rev Cell Dev Biol"},{"key":"3_CR59","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.immunol.22.012703.104549","volume":"22","author":"AP Manderson","year":"2004","unstructured":"Manderson AP, Botto M, Walport MJ (2004) The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 22:431\u2013456","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"3_CR60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1074-7613(01)00257-6","volume":"16","author":"KM Ansel","year":"2002","unstructured":"Ansel KM, Harris RB, Cyster JG (2002) CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 16(1):67\u201376","journal-title":"Immunity"},{"issue":"4","key":"3_CR61","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41593-018-0106-4","volume":"21","author":"S Tanabe","year":"2018","unstructured":"Tanabe S, Yamashita T (2018) B-1a lymphocytes promote oligodendrogenesis during brain development. Nat Neurosci 21(4):506\u2013516","journal-title":"Nat Neurosci"},{"issue":"3","key":"3_CR62","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/cvr\/cvv037","volume":"106","author":"H Hosseini","year":"2015","unstructured":"Hosseini H, Li Y, Kanellakis P et al (2015) Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes. Cardiovasc Res 106(3):443\u2013452","journal-title":"Cardiovasc Res"},{"issue":"6","key":"3_CR63","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","volume":"9","author":"CJ Binder","year":"2003","unstructured":"Binder CJ, Horkko S, Dewan A et al (2003) Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9(6):736\u2013743","journal-title":"Nat Med"},{"issue":"1","key":"3_CR64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI4533","volume":"103","author":"S H\u00f6rkk\u00f6","year":"1999","unstructured":"H\u00f6rkk\u00f6 S, Bird DA, Miller E et al (1999) Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid\u2013protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest 103(1):117\u2013128","journal-title":"J Clin Invest"},{"key":"3_CR65","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","volume":"9","author":"CJ Binder","year":"2003","unstructured":"Binder CJ, H\u00f6rkk\u00f6 S, Dewan A et al (2003) Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 9:736","journal-title":"Nat Med"},{"issue":"8","key":"3_CR66","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/ATVBAHA.108.167197","volume":"28","author":"E Thorp","year":"2008","unstructured":"Thorp E, Cui D, Schrijvers DM et al (2008) Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of Apoe\u2212\/\u2212 mice. Arterioscler Thromb Vasc Biol 28(8):1421\u20131428","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"3_CR67","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1073\/pnas.96.11.6353","volume":"96","author":"MK Chang","year":"1999","unstructured":"Chang MK, Bergmark C, Laurila A et al (1999) Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc Natl Acad Sci U S A 96(11):6353\u20136358","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"3_CR68","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1016\/j.vaccine.2012.03.084","volume":"30","author":"B Suthers","year":"2012","unstructured":"Suthers B, Hansbro P, Thambar S et al (2012) Pneumococcal vaccination may induce anti-oxidized low-density lipoprotein antibodies that have potentially protective effects against cardiovascular disease. Vaccine 30(27):3983\u20133985","journal-title":"Vaccine"},{"key":"3_CR69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fimmu.2012.00066","volume":"3","author":"C Gr\u00f6nwall","year":"2012","unstructured":"Gr\u00f6nwall C, Vas J, Silverman G (2012) Protective roles of natural IgM antibodies. Front Immunol 3:66","journal-title":"Front Immunol"},{"issue":"2","key":"3_CR70","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1194\/jlr.P054569","volume":"56","author":"D Tsiantoulas","year":"2015","unstructured":"Tsiantoulas D, Perkmann T, Afonyushkin T et al (2015) Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies. J Lipid Res 56(2):440\u2013448","journal-title":"J Lipid Res"},{"issue":"22","key":"3_CR71","first-page":"7995","volume":"63","author":"S Br\u00e4ndlein","year":"2003","unstructured":"Br\u00e4ndlein S, Pohle T, Ruoff N et al (2003) Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans. Cancer Res 63(22):7995\u20138005","journal-title":"Cancer Res"},{"issue":"4","key":"3_CR72","first-page":"777","volume":"11","author":"S Brandlein","year":"2004","unstructured":"Brandlein S, Pohle T, Vollmers C et al (2004) CFR-1 receptor as target for tumor-specific apoptosis induced by the natural human monoclonal antibody PAM-1. Oncol Rep 11(4):777\u2013784","journal-title":"Oncol Rep"},{"issue":"1","key":"3_CR73","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1535-7163.MCT-06-0399","volume":"6","author":"S Brandlein","year":"2007","unstructured":"Brandlein S, Rauschert N, Rasche L et al (2007) The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein. Mol Cancer Ther 6(1):326\u2013333","journal-title":"Mol Cancer Ther"},{"issue":"20","key":"3_CR74","first-page":"5299","volume":"59","author":"F Hensel","year":"1999","unstructured":"Hensel F, Hermann R, Schubert C et al (1999) Characterization of glycosylphosphatidylinositol-linked molecule CD55\/decay-accelerating factor as the receptor for antibody SC-1-induced apoptosis. Cancer Res 59(20):5299\u20135306","journal-title":"Cancer Res"},{"issue":"2","key":"3_CR75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/HAB-2001-10205","volume":"10","author":"R Hermann","year":"2001","unstructured":"Hermann R, Hensel F, Muller EC et al (2001) Deactivation of regulatory proteins hnRNP A1 and A2 during SC-1 induced apoptosis. Hum Antibodies 10(2):83\u201390","journal-title":"Hum Antibodies"},{"issue":"3","key":"3_CR76","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/intimm\/dxh053","volume":"16","author":"S Varambally","year":"2004","unstructured":"Varambally S, Bar-Dayan Y, Bayry J et al (2004) Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells. Int Immunol 16(3):517\u2013524","journal-title":"Int Immunol"},{"issue":"4","key":"3_CR77","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3233\/HAB-2002-11401","volume":"11","author":"S Brandlein","year":"2002","unstructured":"Brandlein S, Lorenz J, Ruoff N et al (2002) Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients. Hum Antibodies 11(4):107\u2013119","journal-title":"Hum Antibodies"},{"key":"3_CR78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.immunol.15.1.203","volume":"15","author":"M Daeron","year":"1997","unstructured":"Daeron M (1997) Fc receptor biology. Annu Rev Immunol 15:203\u2013234","journal-title":"Annu Rev Immunol"},{"key":"3_CR79","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.immunol.16.1.421","volume":"16","author":"JV Ravetch","year":"1998","unstructured":"Ravetch JV, Clynes RA (1998) Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol 16:421\u2013432","journal-title":"Annu Rev Immunol"},{"key":"3_CR80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-4614-3461-0_3","volume-title":"Naturally occurring antibodies (NAbs)","author":"R Schwartz-Albiez","year":"2012","unstructured":"Schwartz-Albiez R (2012) Naturally occurring antibodies directed against carbohydrate tumor antigens. In: Lutz HU (ed) Naturally occurring antibodies (NAbs). Springer, New York, NY, pp 27\u201343"},{"issue":"6","key":"3_CR81","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.autrev.2008.03.014","volume":"7","author":"R Erttmann","year":"2008","unstructured":"Erttmann R (2008) Treatment of neuroblastoma with human natural antibodies. Autoimmun Rev 7(6):496\u2013500","journal-title":"Autoimmun Rev"},{"issue":"9","key":"3_CR82","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1073\/pnas.93.9.4498","volume":"93","author":"MW Ollert","year":"1996","unstructured":"Ollert MW, David K, Schmitt C, Hauenschild A et al (1996) Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells. Proc Natl Acad Sci U S A 93(9):4498\u20134503","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3_CR83","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/1096-911X(20010101)36:1<251::AID-MPO1062>3.0.CO;2-Z","volume":"36","author":"K David","year":"2001","unstructured":"David K, Heiligtag S, Ollert MW et al (2001) Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM. Med Pediatr Oncol 36(1):251\u2013257","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"3_CR84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.cmr.0000200490.62723.b0","volume":"16","author":"JMG Larkin","year":"2006","unstructured":"Larkin JMG, Norsworthy PJ, A'Hern RP et al (2006) Anti-\u03b1Gal-dependent complement-mediated cytotoxicity in metastatic melanoma. Melanoma Res 16(2):157\u2013163","journal-title":"Melanoma Res"},{"issue":"6","key":"3_CR85","first-page":"451","volume":"9","author":"CH Poynton","year":"1992","unstructured":"Poynton CH, Jackson S, Fegan C et al (1992) Use of IgM enriched intravenous immunoglobulin (pentaglobin) in bone marrow transplantation. Bone Marrow Transplant 9(6):451\u2013457","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"3_CR86","first-page":"2677","volume":"35","author":"KG Kreymann","year":"2007","unstructured":"Kreymann KG, de Heer G, Nierhaus A et al (2007) Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 35(12):2677\u20132685","journal-title":"Crit Care Med"},{"issue":"6","key":"3_CR87","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2796.2006.01726.x","volume":"260","author":"A Norrby-Teglund","year":"2006","unstructured":"Norrby-Teglund A, Haque KN, Hammarstrom L (2006) Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. J Intern Med 260(6):509\u2013516","journal-title":"J Intern Med"},{"issue":"12","key":"3_CR88","first-page":"1293","volume":"142","author":"KN Haque","year":"1988","unstructured":"Haque KN, Zaidi MH, Bahakim H (1988) IgM-enriched intravenous immunoglobulin therapy in neonatal sepsis. Am J Dis Child (1960) 142(12):1293\u20131296","journal-title":"Am J Dis Child (1960)"},{"issue":"2","key":"3_CR89","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/shk.0b013e318067df15","volume":"29","author":"SN Stehr","year":"2008","unstructured":"Stehr SN, Knels L, Weissflog C et al (2008) Effects of IGM-enriched solution on polymorphonuclear neutrophil function, bacterial clearance, and lung histology in endotoxemia. Shock (Augusta, GA) 29(2):167\u2013172","journal-title":"Shock (Augusta, GA)"},{"issue":"3","key":"3_CR90","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood.V93.3.942","volume":"93","author":"R Rieben","year":"1999","unstructured":"Rieben R, Roos A, Muizert YT et al (1999) Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 93(3):942\u2013951","journal-title":"Blood"},{"issue":"11","key":"3_CR91","doi-asserted-by":"crossref","first-page":"e1001077","DOI":"10.1371\/journal.ppat.1001077","volume":"6","author":"MS Maddur","year":"2010","unstructured":"Maddur MS, Vani J, Lacroix-Desmazes S et al (2010) Autoimmunity as a predisposition for infectious diseases. PLoS Pathog 6(11):e1001077","journal-title":"PLoS Pathog"},{"key":"3_CR92","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1093\/clinids\/21.Supplement_2.S186","volume":"21","author":"MB Marcia","year":"1995","unstructured":"Marcia MB, Neelima MB, Nelson NHT (1995) Anti-endotoxin human monoclonal antibody A6H4C5 (HA-1A) utilizes the VH4.21 gene. Clin Infect Dis 21:S186\u2013S1S9","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3_CR93","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1182\/blood.V90.10.4004","volume":"90","author":"V Hurez","year":"1997","unstructured":"Hurez V, Kazatchkine MD, Vassilev T et al (1997) Pooled normal human polyspecific IgM contains neutralizing anti-idiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease. Blood 90(10):4004\u20134013","journal-title":"Blood"},{"issue":"8","key":"3_CR94","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2436::AID-IMMU2436>3.0.CO;2-9","volume":"29","author":"T Vassilev","year":"1999","unstructured":"Vassilev T, Yamamoto M, Aissaoui A et al (1999) Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice. Eur J Immunol 29(8):2436\u20132442","journal-title":"Eur J Immunol"},{"issue":"1","key":"3_CR95","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2249.2006.03098.x","volume":"145","author":"T Vassilev","year":"2006","unstructured":"Vassilev T, Mihaylova N, Voynova E et al (2006) IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice. Clin Exp Immunol 145(1):108\u2013115","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"3_CR96","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/jaut.1993.1018","volume":"6","author":"DR Jayne","year":"1993","unstructured":"Jayne DR, Esnault VL, Lockwood CM (1993) ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin. J Autoimmun 6(2):207\u2013219","journal-title":"J Autoimmun"},{"issue":"2","key":"3_CR97","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2249.1991.tb05631.x","volume":"83","author":"F Rossi","year":"1991","unstructured":"Rossi F, Jayne DR, Lockwood CM et al (1991) Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol 83(2):298\u2013303","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"3_CR98","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1002\/art.21252","volume":"52","author":"S Yehuda","year":"2005","unstructured":"Yehuda S, Elias T (2005) Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential. Arthritis Rheum 52(9):2599\u20132606","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3_CR99","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/art.1780250307","volume":"25","author":"WK Bolton","year":"1982","unstructured":"Bolton WK, Schrock JH, Davis JS IV (1982) Rheumatoid factor inhibition of in vitro binding of IgG complexes in the human glomerulus. Arthritis Rheum 25(3):297\u2013303","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3_CR100","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0896-8411(91)90169-D","volume":"4","author":"A Andersson","year":"1991","unstructured":"Andersson A, Forsgren S, Soderstrom A et al (1991) Monoclonal, natural antibodies prevent development of diabetes in the non-obese diabetic (NOD) mouse. J Autoimmun 4(5):733\u2013742","journal-title":"J Autoimmun"},{"issue":"2","key":"3_CR101","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1399-3089.2003.00098.x","volume":"11","author":"AJ Walpen","year":"2004","unstructured":"Walpen AJ, Laumonier T, Aebi C et al (2004) Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum. Xenotransplantation 11(2):141\u2013148","journal-title":"Xenotransplantation"},{"issue":"11","key":"3_CR102","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.4049\/jimmunol.1500052","volume":"195","author":"PI Lobo","year":"2015","unstructured":"Lobo PI, Schlegel KH, Bajwa A et al (2015) Natural IgM switches the function of lipopolysaccharide-activated murine bone marrow-derived dendritic cells to a regulatory dendritic cell that suppresses innate inflammation. J Immunol 195(11):5215\u20135226","journal-title":"J Immunol"},{"issue":"4","key":"3_CR103","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.4049\/jimmunol.1101762","volume":"188","author":"PI Lobo","year":"2012","unstructured":"Lobo PI, Bajwa A, Schlegel KH et al (2012) Natural IgM anti-leukocyte autoantibodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17. J Immunol 188(4):1675\u20131685","journal-title":"J Immunol"},{"issue":"11","key":"3_CR104","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nri2849","volume":"10","author":"MR Ehrenstein","year":"2010","unstructured":"Ehrenstein MR, Notley CA (2010) The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 10(11):778\u2013786","journal-title":"Nat Rev Immunol"},{"issue":"17","key":"3_CR105","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1002\/elps.200305992","volume":"25","author":"M Bibl","year":"2004","unstructured":"Bibl M, Esselmann H, Otto M et al (2004) Cerebrospinal fluid amyloid beta peptide patterns in Alzheimer\u2019s disease patients and nondemented controls depend on sample pretreatment: indication of carrier-mediated epitope masking of amyloid beta peptides. Electrophoresis 25(17):2912\u20132918","journal-title":"Electrophoresis"},{"issue":"1","key":"3_CR106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JAD-2007-12105","volume":"12","author":"E Giacobini","year":"2007","unstructured":"Giacobini E, Becker RE (2007) One hundred years after the discovery of Alzheimer\u2019s disease. A turning point for therapy? J Alzheimers Dis 12(1):37\u201352","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"3_CR107","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard F, Cannon C, Barbour R et al (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6(8):916\u2013919","journal-title":"Nat Med"},{"issue":"84","key":"3_CR108","first-page":"319","volume":"15","author":"D Lambracht-Washington","year":"2013","unstructured":"Lambracht-Washington D, Rosenberg RN (2013) Advances in the development of vaccines for Alzheimer\u2019s disease. Discov Med 15(84):319\u2013326","journal-title":"Discov Med"},{"issue":"2","key":"3_CR109","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.expneurol.2007.05.005","volume":"206","author":"WA Banks","year":"2007","unstructured":"Banks WA, Farr SA, Morley JE et al (2007) Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer\u2019s disease: an age-related selective uptake with reversal of learning impairment. Exp Neurol 206(2):248\u2013256","journal-title":"Exp Neurol"},{"issue":"8","key":"3_CR110","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.neurobiolaging.2009.08.011","volume":"32","author":"A Marcello","year":"2011","unstructured":"Marcello A, Wirths O, Schneider-Axmann T, Degerman-Gunnarsson M, Lannfelt L, Bayer TA (2011) Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Abeta in plasma of patients with Alzheimer\u2019s disease. Neurobiol Aging 32(8):1379\u20131387","journal-title":"Neurobiol Aging"},{"issue":"8","key":"3_CR111","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1074\/jbc.M707983200","volume":"283","author":"H Taguchi","year":"2008","unstructured":"Taguchi H, Planque S, Nishiyama Y et al (2008) Autoantibody-catalyzed hydrolysis of amyloid beta peptide. J Biol Chem 283(8):4714\u20134722","journal-title":"J Biol Chem"},{"key":"3_CR112","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1749-6632.1984.tb14779.x","volume":"436","author":"W Lang","year":"1984","unstructured":"Lang W, Rodriguez M, Lennon VA et al (1984) Demyelination and remyelination in murine viral encephalomyelitis. Ann N Y Acad Sci 436:98\u2013102","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"3_CR113","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0022-510X(82)90061-2","volume":"56","author":"U Traugott","year":"1982","unstructured":"Traugott U, Stone SH, Raine CS (1982) Chronic relapsing experimental autoimmune encephalomyelitis. treatment with combinations of myelin components promotes clinical and structural recovery. J Neurol Sci 56(1):65\u201373","journal-title":"J Neurol Sci"},{"issue":"1","key":"3_CR114","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0882-4010(90)90005-B","volume":"8","author":"M Rodriguez","year":"1990","unstructured":"Rodriguez M, Kenny JJ, Thiemann RL et al (1990) Theiler\u2019s virus-induced demyelination in mice immunosuppressed with anti-IgM and in mice expressing the xid gene. Microb Pathog 8(1):23\u201335","journal-title":"Microb Pathog"},{"issue":"1","key":"3_CR115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.410270104","volume":"27","author":"M Rodriguez","year":"1990","unstructured":"Rodriguez M, Lennon VA (1990) Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 27(1):12\u201317","journal-title":"Ann Neurol"},{"issue":"3","key":"3_CR116","first-page":"358","volume":"64","author":"M Rodriguez","year":"1991","unstructured":"Rodriguez M (1991) Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells. Lab Investig 64(3):358\u2013370","journal-title":"Lab Investig"},{"issue":"1","key":"3_CR117","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00005072-198701000-00008","volume":"46","author":"M Rodriguez","year":"1987","unstructured":"Rodriguez M, Lennon VA, Benveniste EN et al (1987) Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol 46(1):84\u201395","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"3_CR118","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1523\/JNEUROSCI.14-10-06230.1994","volume":"14","author":"DJ Miller","year":"1994","unstructured":"Miller DJ, Sanborn KS, Katzmann JA et al (1994) Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis. J Neurosci 14(10):6230\u20136238","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"3_CR119","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0165-5728(97)00027-1","volume":"75","author":"DJ Miller","year":"1997","unstructured":"Miller DJ, Bright JJ, Sriram S et al (1997) Successful treatment of established relapsing experimental autoimmune encephalomyelitis in mice with a monoclonal natural autoantibody. J Neuroimmunol 75(1\u20132):204\u2013209","journal-title":"J Neuroimmunol"},{"issue":"19","key":"3_CR120","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1523\/JNEUROSCI.18-19-07700.1998","volume":"18","author":"K Asakura","year":"1998","unstructured":"Asakura K, Miller DJ, Pease LR et al (1998) Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci 18(19):7700\u20137708","journal-title":"J Neurosci"},{"issue":"12","key":"3_CR121","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.97.12.6820","volume":"97","author":"AE Warrington","year":"2000","unstructured":"Warrington AE, Asakura K, Bieber AJ et al (2000) Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A 97(12):6820\u20136825","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3_CR122","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/glia.10033","volume":"37","author":"AJ Bieber","year":"2002","unstructured":"Bieber AJ, Warrington A, Asakura K et al (2002) Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice. Glia 37(3):241\u2013249","journal-title":"Glia"},{"issue":"10","key":"3_CR123","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1096\/fj.01-0994fje","volume":"16","author":"Y Mitsunaga","year":"2002","unstructured":"Mitsunaga Y, Ciric B, Van Keulen V et al (2002) Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J 16(10):1325\u20131327","journal-title":"FASEB J"},{"issue":"8","key":"3_CR124","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1007\/s12035-015-9436-3","volume":"53","author":"B Wootla","year":"2016","unstructured":"Wootla B, Denic A, Watzlawik JO et al (2016) Antibody-mediated oligodendrocyte remyelination promotes axon health in progressive demyelinating disease. Mol Neurobiol 53(8):5217\u20135228","journal-title":"Mol Neurobiol"},{"issue":"1\u20132","key":"3_CR125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2003.11.002","volume":"146","author":"B Ciric","year":"2004","unstructured":"Ciric B, Van Keulen V, Paz Soldan M, Rodriguez M, Pease LR (2004) Antibody-mediated remyelination operates through mechanism independent of immunomodulation. J Neuroimmunol 146(1\u20132):153\u2013161","journal-title":"J Neuroimmunol"},{"key":"3_CR126","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nbd.2017.05.015","volume":"105","author":"AP Mullin","year":"2017","unstructured":"Mullin AP, Cui C, Wang Y et al (2017) rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination. Neurobiol Dis 105:142\u2013155","journal-title":"Neurobiol Dis"},{"issue":"12","key":"3_CR127","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/archneurol.2009.262","volume":"66","author":"BR Wright","year":"2009","unstructured":"Wright BR, Warrington AE, Edberg DD et al (2009) Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies. Arch Neurol 66(12):1456\u20131459","journal-title":"Arch Neurol"},{"key":"3_CR128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.brainres.2018.05.013","volume":"1694","author":"C Cui","year":"2018","unstructured":"Cui C, Wang J, Mullin AP et al (2018) The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination. Brain Res 1694:73\u201386","journal-title":"Brain Res"},{"issue":"12","key":"3_CR129","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0196-9781(02)00261-9","volume":"23","author":"WA Banks","year":"2002","unstructured":"Banks WA, Terrell B, Farr SA et al (2002) Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer\u2019s disease. Peptides 23(12):2223\u20132226","journal-title":"Peptides"},{"issue":"13","key":"3_CR130","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1096\/fj.04-2026fje","volume":"18","author":"I Pirko","year":"2004","unstructured":"Pirko I, Ciric B, Gamez J et al (2004) A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. FASEB J 18(13):1577\u20131579","journal-title":"FASEB J"},{"issue":"5","key":"3_CR131","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jnr.21217","volume":"85","author":"AE Warrington","year":"2007","unstructured":"Warrington AE, Bieber AJ, Ciric B et al (2007) A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res 85(5):967\u2013976","journal-title":"J Neurosci Res"},{"issue":"3","key":"3_CR132","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/(SICI)1097-4547(19960201)43:3<273::AID-JNR2>3.0.CO;2-G","volume":"43","author":"K Asakura","year":"1996","unstructured":"Asakura K, Miller DJ, Murray K et al (1996) Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res 43(3):273\u2013281","journal-title":"J Neurosci Res"},{"issue":"1","key":"3_CR133","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nbd.2003.09.002","volume":"15","author":"CL Howe","year":"2004","unstructured":"Howe CL, Bieber AJ, Warrington AE et al (2004) Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis 15(1):120\u2013131","journal-title":"Neurobiol Dis"},{"issue":"15","key":"3_CR134","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/glia.21048","volume":"58","author":"J Watzlawik","year":"2010","unstructured":"Watzlawik J, Holicky E, Edberg DD et al (2010) Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytes. Glia 58(15):1782\u20131793","journal-title":"Glia"},{"issue":"14","key":"3_CR135","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1021\/ac300819a","volume":"84","author":"NJ Wittenberg","year":"2012","unstructured":"Wittenberg NJ, Im H, Xu X et al (2012) High-affinity binding of remyelinating natural autoantibodies to myelin-mimicking lipid bilayers revealed by nanohole surface plasmon resonance. Anal Chem 84(14):6031\u20136039","journal-title":"Anal Chem"},{"issue":"1","key":"3_CR136","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1044-7431(02)00018-0","volume":"22","author":"MM Paz Soldan","year":"2003","unstructured":"Paz Soldan MM, Warrington AE, Bieber AJ et al (2003) Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci 22(1):14\u201324","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"3_CR137","doi-asserted-by":"crossref","first-page":"e55149","DOI":"10.1371\/journal.pone.0055149","volume":"8","author":"JO Watzlawik","year":"2013","unstructured":"Watzlawik JO, Warrington AE, Rodriguez M (2013) PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation. PLoS One 8(2):e55149","journal-title":"PLoS One"},{"issue":"11","key":"3_CR138","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/NEN.0b013e3181587d46","volume":"66","author":"AC Vana","year":"2007","unstructured":"Vana AC, Flint NC, Harwood NE et al (2007) Platelet-derived growth factor promotes repair of chronically demyelinated white matter. J Neuropathol Exp Neurol 66(11):975\u2013988","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"3_CR139","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/ncb865","volume":"4","author":"H Colognato","year":"2002","unstructured":"Colognato H, Baron W, Avellana-Adalid V et al (2002) CNS integrins switch growth factor signalling to promote target-dependent survival. Nat Cell Biol 4(11):833\u2013841","journal-title":"Nat Cell Biol"},{"issue":"21","key":"3_CR140","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0960-9822(99)80506-5","volume":"9","author":"EE Frost","year":"1999","unstructured":"Frost EE, Buttery PC, Milner R et al (1999) Integrins mediate a neuronal survival signal for oligodendrocytes. Curr Biol 9(21):1251\u20131254","journal-title":"Curr Biol"},{"issue":"8","key":"3_CR141","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/emboj\/21.8.1957","volume":"21","author":"W Baron","year":"2002","unstructured":"Baron W, Shattil SJ, Ffrench-Constant C (2002) The oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of alpha(v)beta3 integrins. EMBO J 21(8):1957\u20131966","journal-title":"EMBO J"},{"issue":"3","key":"3_CR142","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.nbd.2006.06.012","volume":"23","author":"CL Howe","year":"2006","unstructured":"Howe CL, Mayoral S, Rodriguez M (2006) Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1beta. Neurobiol Dis 23(3):731\u2013739","journal-title":"Neurobiol Dis"},{"issue":"1","key":"3_CR143","doi-asserted-by":"crossref","first-page":"9392","DOI":"10.1038\/s41598-018-27559-y","volume":"8","author":"Y Zorina","year":"2018","unstructured":"Zorina Y, Stricker J, Caggiano AO et al (2018) Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia. Sci Rep 8(1):9392","journal-title":"Sci Rep"},{"issue":"1","key":"3_CR144","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1471-4159.2011.07416.x","volume":"119","author":"X Xu","year":"2011","unstructured":"Xu X, Warrington AE, Wright BR et al (2011) A human IgM signals axon outgrowth: coupling lipid raft to microtubules. J Neurochem 119(1):100\u2013112","journal-title":"J Neurochem"},{"key":"3_CR145","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/srep02267","volume":"3","author":"X Xu","year":"2013","unstructured":"Xu X, Wittenberg NJ, Jordan LR et al (2013) A patterned recombinant human IgM guides neurite outgrowth of CNS neurons. Sci Rep 3:2267","journal-title":"Sci Rep"},{"issue":"4","key":"3_CR146","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.21758","volume":"66","author":"A Denic","year":"2009","unstructured":"Denic A, Bieber A, Warrington A et al (2009) Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: marker of demyelination and repair in spinal cord. Ann Neurol 66(4):559\u2013564","journal-title":"Ann Neurol"},{"key":"3_CR147","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12974-015-0303-y","volume":"12","author":"B Wootla","year":"2015","unstructured":"Wootla B, Denic A, Watzlawik JO et al (2015) A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis. J Neuroinflammation 12:83","journal-title":"J Neuroinflammation"},{"issue":"8","key":"3_CR148","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1242\/dmm.020727","volume":"8","author":"X Xu","year":"2015","unstructured":"Xu X, Denic A, Jordan LR et al (2015) A natural human IgM that binds to gangliosides is therapeutic in murine models of amyotrophic lateral sclerosis. Dis Model Mech 8(8):831\u2013842","journal-title":"Dis Model Mech"},{"issue":"3","key":"3_CR149","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1073\/pnas.92.3.689","volume":"92","author":"ME Ripps","year":"1995","unstructured":"Ripps ME, Huntley GW, Hof PR et al (1995) Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 92(3):689\u2013693","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5 Pt 1","key":"3_CR150","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1083\/jcb.101.5.1921","volume":"101","author":"EG Pollerberg","year":"1985","unstructured":"Pollerberg EG, Sadoul R, Goridis C et al (1985) Selective expression of the 180-kD component of the neural cell adhesion molecule N-CAM during development. J Cell Biol 101(5 Pt 1):1921\u20131929","journal-title":"J Cell Biol"},{"issue":"32","key":"3_CR151","doi-asserted-by":"crossref","first-page":"10784","DOI":"10.1523\/JNEUROSCI.0297-10.2010","volume":"30","author":"R Kleene","year":"2010","unstructured":"Kleene R, Mzoughi M, Joshi G et al (2010) NCAM-induced neurite outgrowth depends on binding of calmodulin to NCAM and on nuclear import of NCAM and fak fragments. J Neurosci 30(32):10784\u201310798","journal-title":"J Neurosci"},{"issue":"23","key":"3_CR152","doi-asserted-by":"crossref","first-page":"10335","DOI":"10.1073\/pnas.1005637107","volume":"107","author":"J Giza","year":"2010","unstructured":"Giza J, Biederer T (2010) Polysialic acid: a veteran sugar with a new site of action in the brain. Proc Natl Acad Sci U S A 107(23):10335\u201310336","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"3_CR153","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.5966\/sctm.2014-0041","volume":"3","author":"M Czepiel","year":"2014","unstructured":"Czepiel M, Leicher L, Becker K et al (2014) Overexpression of polysialylated neural cell adhesion molecule improves the migration capacity of induced pluripotent stem cell-derived oligodendrocyte precursors. Stem Cells Transl Med 3(9):1100\u20131109","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"3_CR154","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/jnc.13121","volume":"134","author":"JO Watzlawik","year":"2015","unstructured":"Watzlawik JO, Kahoud RJ, Ng S et al (2015) Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders. J Neurochem 134(5):865\u2013878","journal-title":"J Neurochem"},{"issue":"5","key":"3_CR155","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jnen\/63.5.461","volume":"63","author":"AE Warrington","year":"2004","unstructured":"Warrington AE, Bieber AJ, Van Keulen V et al (2004) Neuron-binding human monoclonal antibodies support central nervous system neurite extension. J Neuropathol Exp Neurol 63(5):461\u2013473","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Suppl 1","key":"3_CR156","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1007\/s10875-012-9795-8","volume":"33","author":"X Xu","year":"2013","unstructured":"Xu X, Denic A, Warrington AE et al (2013) Therapeutics to promote CNS repair: a natural human neuron-binding IgM regulates membrane-raft dynamics and improves motility in a mouse model of multiple sclerosis. J Clin Immunol 33(Suppl 1):S50\u2013S56","journal-title":"J Clin Immunol"},{"issue":"5","key":"3_CR157","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.sbi.2009.06.001","volume":"19","author":"PH Lopez","year":"2009","unstructured":"Lopez PH, Schnaar RL (2009) Gangliosides in cell recognition and membrane protein regulation. Curr Opin Struct Biol 19(5):549\u2013557","journal-title":"Curr Opin Struct Biol"},{"issue":"12","key":"3_CR158","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.1073\/pnas.072211699","volume":"99","author":"AA Vyas","year":"2002","unstructured":"Vyas AA, Patel HV, Fromholt SE et al (2002) Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci U S A 99(12):8412\u20138417","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"3_CR159","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.96.13.7532","volume":"96","author":"KA Sheikh","year":"1999","unstructured":"Sheikh KA, Sun J, Liu Y et al (1999) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A 96(13):7532\u20137537","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3_CR160","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1523\/JNEUROSCI.5204-08.2009","volume":"29","author":"T Nguyen","year":"2009","unstructured":"Nguyen T, Mehta NR, Conant K et al (2009) Axonal protective effects of the myelin-associated glycoprotein. J Neurosci 29(3):630\u2013637","journal-title":"J Neurosci"},{"issue":"1","key":"3_CR161","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2011.11.017","volume":"36","author":"E Montecino-Rodriguez","year":"2012","unstructured":"Montecino-Rodriguez E, Dorshkind K (2012) B-1 B cell development in the fetus and adult. Immunity 36(1):13\u201321","journal-title":"Immunity"},{"issue":"6","key":"3_CR162","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1534-5807(03)00155-2","volume":"4","author":"J Nakahara","year":"2003","unstructured":"Nakahara J, Tan-Takeuchi K, Seiwa C et al (2003) Signaling via immunoglobulin Fc receptors induces oligodendrocyte precursor cell differentiation. Dev Cell 4(6):841\u2013852","journal-title":"Dev Cell"},{"issue":"39","key":"3_CR163","doi-asserted-by":"crossref","first-page":"9881","DOI":"10.1523\/JNEUROSCI.2246-06.2006","volume":"26","author":"JA Nielsen","year":"2006","unstructured":"Nielsen JA, Maric D, Lau P et al (2006) Identification of a novel oligodendrocyte cell adhesion protein using gene expression profiling. J Neurosci 26(39):9881\u20139891","journal-title":"J Neurosci"}],"container-title":["Methods in Molecular Biology","Human Monoclonal Antibodies"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8958-4_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T01:05:21Z","timestamp":1694480721000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8958-4_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,12]]},"ISBN":["9781493989577","9781493989584"],"references-count":163,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8958-4_3","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,12]]}}}